Bafna Pharma.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE878I01022
  • NSEID: BAFNAPH
  • BSEID: 532989
INR
111.32
-0.64 (-0.57%)
BSENSE

Apr 02

BSE+NSE Vol: 2.39 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 852453,
    "name": "Bafna Pharma.",
    "stock_name": "Bafna Pharma.",
    "full_name": "Bafna Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/bafna-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "111.32",
    "chg": -0.64,
    "chgp": "-0.57%",
    "dir": -1,
    "prev_price": "111.96",
    "mcapval": "270.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532989,
    "symbol": "BAFNAPH",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE878I01022",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "2.39 k",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bafna-pharma-852453-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Bafna Pharmaceuticals Declines 2.16%: Circuit Hits and Volatility Mark the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-declines-216-circuit-hits-and-volatility-mark-the-week-3932051",
        "imagepath": "",
        "date": "2026-04-04 15:04:27",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>30 Mar:</strong> Lower circuit hit at Rs.108.42 amid heavy selling pressure</p>\n                    <p><strong>1 Apr:</strong> Upper circuit hit at Rs.114.80 on strong buying interest</p>\n                    <p><strong>2 Apr:</strong> Price correction to Rs.111.00 following volatile sessions</p>\n                    <p><strong>3 Apr:</strong> Week closes at Rs.111.00, down 2.16% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.113.45</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat..."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-pressure-3928602",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BafnaPharmaceut_stocks_hitting_upper_circuit_3928602.png",
        "date": "2026-04-01 10:00:56",
        "description": "At Rs 114.80, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 4.99% on 1 Apr 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Locks at Lower Circuit With 4.99% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3925521",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BafnaPharmaceut_stocks_hitting_lower_circuit_3925521.png",
        "date": "2026-03-30 15:00:08",
        "description": "At Rs 108.42, sellers were still queuing — but there were no buyers willing to take the other side. Bafna Pharmaceuticals Ltd locked at its lower circuit of 4.99% on 30 Mar 2026, with unfilled sell orders and a frozen price, reflecting a day where supply overwhelmed demand to the point the exchange intervened."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Locks at Lower Circuit With 5% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3919408",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BafnaPharmaceut_stocks_hitting_lower_circuit_3919408.png",
        "date": "2026-03-27 12:00:11",
        "description": "At Rs 111.84, sellers were still queuing — but there were no buyers willing to take the other side. Bafna Pharmaceuticals Ltd locked at its lower circuit of 5% on 27 Mar 2026, with unfilled sell orders and a frozen price."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bafna-pharmaceuticals-ltd-is-rated-strong-sell-3919015",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BafnaPharmaceut_mojoScore_3919015.png",
        "date": "2026-03-27 10:10:03",
        "description": "Bafna Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 March 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 27 March 2026, providing investors with the most up-to-date insight into the company’s performance and outlook."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Locks at Lower Circuit With 5% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3915771",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BafnaPharmaceut_stocks_hitting_lower_circuit_3915771.png",
        "date": "2026-03-25 10:00:12",
        "description": "At Rs 107.99, sellers were still queuing — but there were no buyers willing to take the other side. Bafna Pharmaceuticals Ltd locked at its lower circuit of 5% on 25 Mar 2026, with unfilled sell orders and a frozen price."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Locks at Lower Circuit With 5.0% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3910560",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BafnaPharmaceut_stocks_hitting_lower_circuit_3910560.png",
        "date": "2026-03-24 13:00:07",
        "description": "At Rs 113.67, sellers were still queuing — but there were no buyers willing to take the other side. Bafna Pharmaceuticals Ltd locked at its lower circuit of 5.0% on 24 Mar 2026, with unfilled sell orders and a frozen price."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Locks at Lower Circuit With 4.99% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3906868",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BafnaPharmaceut_stocks_hitting_lower_circuit_3906868.png",
        "date": "2026-03-23 10:00:21",
        "description": "At Rs 119.65, sellers were still queuing — but there were no buyers willing to take the other side. Bafna Pharmaceuticals Ltd locked at its lower circuit of 4.99% on 23 Mar 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock."
      },
      {
        "title": "Bafna Pharmaceuticals Gains 27.46%: 6 Key Factors Driving the Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-gains-2746-6-key-factors-driving-the-surge-3905348",
        "imagepath": "",
        "date": "2026-03-21 15:04:33",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Mar:</strong> Downgrade to Strong Sell; stock hits upper circuit at Rs.104.11 (+4.99%)</p>\n                    <p><strong>17 Mar:</strong> Upper circuit hit again at Rs.109.31 (+4.99%) with rising delivery volumes</p>\n                    <p><strong>18 Mar:</strong> Third consecutive upper circuit close at Rs.114.77 (+4.99%) amid volatile trading</p>\n                    <p><strong>19 Mar:</strong> Fourth upper circuit close at Rs.119.15 (+4.89%) with increased investor participation</p>\n                    <p><strong>20 Mar:</strong> Fifth consecutive upper circuit close at Rs.125.10 (+4.99%) with strong delivery volume surge</p>\n                </div>\n\n                <div clas..."
      }
    ],
    "total": 294,
    "sid": "852453",
    "stock_news_url": "https://www.marketsmojo.com/news/bafna-pharmaceuticals-852453"
  },
  "announcements": [
    {
      "details": "Bafna Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on November 13, 2019.",
      "source": "NSE",
      "caption": "Bafna Pharmaceuticals Limited - Outcome of Board Meeting",
      "datetime": "14-Nov-2019"
    },
    {
      "details": " <table><tr><td>The Exchange had sought clarification from Bafna Pharmaceuticals Limited for the quarter ended 30-Jun-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is enclosed. </td></tr></table>",
      "source": "NSE",
      "caption": "Reply to Clarification- Financial results",
      "datetime": "27-Aug-2019"
    },
    {
      "details": " <table><tr><td>BAFNAPHARM: Members of the Exchange are hereby informed that the trading in Equity Shares of Bafna Pharmaceuticals Limited shall be suspended w.e.f. August 26, 2019 (i.e. closing hours of trading on August 23, 2019) on account of Reduction of Share Capital. </td></tr></table>",
      "source": "NSE",
      "caption": "Suspension of trading in equity shares",
      "datetime": "21-Aug-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bafna Pharmaceuticals Ltd has declared <strong>6%</strong> dividend, ex-date: 19 Sep 13",
          "dt": "2013-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Bafna Pharmaceuticals Declines 2.16%: Circuit Hits and Volatility Mark the Week

2026-04-04 15:04:27

Key Events This Week

30 Mar: Lower circuit hit at Rs.108.42 amid heavy selling pressure

1 Apr: Upper circuit hit at Rs.114.80 on strong buying interest

2 Apr: Price correction to Rs.111.00 following volatile sessions

3 Apr: Week closes at Rs.111.00, down 2.16% for the week

stock-recommendationAnnouncement

Bafna Pharmaceuticals Limited - Outcome of Board Meeting

14-Nov-2019 | Source : NSE

Bafna Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on November 13, 2019.

Reply to Clarification- Financial results

27-Aug-2019 | Source : NSE

The Exchange had sought clarification from Bafna Pharmaceuticals Limited for the quarter ended 30-Jun-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is enclosed.

Suspension of trading in equity shares

21-Aug-2019 | Source : NSE

BAFNAPHARM: Members of the Exchange are hereby informed that the trading in Equity Shares of Bafna Pharmaceuticals Limited shall be suspended w.e.f. August 26, 2019 (i.e. closing hours of trading on August 23, 2019) on account of Reduction of Share Capital.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Bafna Pharmaceuticals Ltd has declared 6% dividend, ex-date: 19 Sep 13

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available